RxDoctor Payments Data

Nicholas Landry, DO

Family Medicine · Gallipolis, OHNPI 1992781538

Payments from drug & device makers

$29,279in general payments, 2019–2025

Across 152 payments — averaging $192.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$27K
  • Hikma Pharmaceuticals USA$1K
  • Gilead$698
  • Alkermes, Inc.$89
  • AbbVie$88
  • Johnson & Johnson$77
  • plus $267 from 10 others

What the payments were for

  • Consulting fees$1,2004%
  • Speaking & faculty fees$22,20076%
  • Travel & lodging$2,5699%
  • Food & beverage$3,26511%
  • Education$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,279 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$25,506
Medicare patients
14
Services billed
431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SublocadeBuprenorphine15$31,417
Spiriva HandihalerTiotropium Bromide13$6,705
Arnuity ElliptaFluticasone Furoate11$3,375
Colestipol Hcl27$2,831
Ezetimibe29$1,975
BreynaBudesonide/Formoterol Fumarate11$1,361
Aripiprazole15$1,219
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39$808
Ventolin HfaAlbuterol Sulfate13$728
Phenobarbital12$642
Fluticasone Propionate52$413
Diclofenac Sodium ErDiclofenac Sodium12$402
Omeprazole67$359
Oxycodone Hcl26$314
Rosuvastatin Calcium68$298

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Sublocade$26,859$31,41715 claims
Hikma Pharmaceuticals USAPhenobarbital$1,200$64212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Gallipolis

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →